WEBULL
WebtradeDownload

Synlait Milk (NZSE:SML) Stock Can Recovery Hopes Outrun Deepening Losses?

Simply Wall St · 2d ago

Synlait Milk closed at NZ$0.43 on Tuesday, barely higher over the past month, which indicates investors came into these results cautious rather than euphoric. The headline is blunt. The dairy processor remains loss making, with a reported net loss after tax of NZ$75.4m for FY26, while management is pointing to a sharp swing in underlying earnings in the second half and a trimmed net debt position of NZ$215m as the foundations for any longer term recovery story.

Is Synlait Milk trading at a genuine discount, or does its price simply reflect the risk of ongoing losses and volatile sentiment around NZSE:SML? See how the current pricing compares to cash flow expectations and peer multiples in the valuation analysis for Synlait Milk.

FY 2026 Earnings Summary

  • Revenue (FY26 vs FY25, trailing twelve months): NZ$1,682.29m vs. NZ$1,827.42m (decline of 7.9%)
  • Net Loss (FY26 vs FY25, trailing twelve months, continuing operations): NZ$91.55m loss vs. NZ$39.82m loss (loss widened by 129.9%)
  • Basic EPS (Earnings Per Share) (FY26 vs FY25, trailing twelve months): NZ$0.1518 loss per share vs. NZ$0.0739 loss per share (per share loss increased by 105.4%)
  • Net Loss Including Discontinued Operations (FY26 vs FY25, trailing twelve months): NZ$75.44m loss vs. NZ$39.82m loss (loss increased by 89.4%)

Prefer clean visuals instead of another dense block of earnings commentary and loss figures for Synlait Milk? See the full picture in an interactive format with a clear view of the balance sheet and funding position in the company report for Synlait Milk.

NZSE:SML Trailing 12-Month Earnings & Revenue History as at Sep 2026
NZSE:SML Trailing 12-Month Earnings & Revenue History as at Sep 2026

Evaluating Synlait Milk’s Recovery Milestones

Bulls argue Synlait Milk can shift from bulk commodities to higher value nutrition and consumer products, with efficiency gains rebuilding profitability. Parts of that script are visible. Foodservice revenue rose 62% with 43% volume growth and moved into clear profitability, adding about NZ$15.6m of gross profit to reach NZ$11m. Consumer and Dairyworks revenue climbed 32%, helped by extra cheese volumes into Australia and stronger Costco sales, so the branded and premium side is gaining traction.

Operationally, management has sold the North Island assets and is refocusing on Dunsandel, while net debt is trimmed to NZ$215m. This supports the “stabilise and simplify” phase. The weak point is Advanced Nutrition. Revenue held up but gross profit fell about 78%, which directly contradicts the idea that higher value nutrition is already the earnings engine. On commercialisation, Nutrabase is live and a new Middle East infant nutrition customer is secured, although material volumes are still in the future.

Access the analyst estimates for Synlait Milk to see where the consensus models start to diverge on Synlait Milk’s next few reporting seasons and whether the calm share price at NZ$0.43 masks a much sharper move in the multi year earnings path.

Synlait Milk Bears Still Own The Earnings Tape

Bears argue Synlait Milk is a leveraged dairy processor with fragile demand, heavy customer reliance and thin room for error. The latest year does not remove those concerns. Group revenue of about NZ$1.94b sat alongside a reported net loss of NZ$75.4m and an underlying loss of NZ$21.6m, so the business is still not earning its cost of capital. Operating cash outflow of NZ$183.3m, even with net debt trimmed to NZ$215m after asset sales, supports the view that leverage risk is more about weak cash generation than headline borrowings.

Advanced Nutrition was supposed to be the quality growth engine. Instead, gross profit fell about 78% while the new Middle East infant customer does not deliver volume until 2027. That validates fears around demand and customer concentration, since capacity vacated by a2 Milk is not yet clearly replaced on economic terms.

After a year where Advanced Nutrition gross profit fell 78% and cash generation stayed weak, review our independent risk analysis for Synlait Milk which shows 1 important warning sign to see whether these strains hint at deeper structural vulnerabilities or other warning signs the market has not fully priced in.

Take Charge Of Your Next Move

If Synlait Milk’s widening losses and mixed recovery signals have your attention, register for free with Simply Wall St and add it to your Watchlist so you can track the share price against fair value estimates and wait for a setup that fits your own risk tolerance. Once you are invested, use the Portfolio Command Center to cut through noise and focus on concise alerts about earnings, balance sheet shifts and valuation changes that are relevant to your holdings. For longer term context, turn to the Community to see how other investors are interpreting the same data and which risks or potential catalysts they are watching. Identifying potential turning points early may help you stay informed about major moves and act before the wider market fully reacts.

Seeking Alternatives Beyond Synlait Milk?

Fresh opportunities move fast. Some are already building breakout momentum while others are still under the radar for now. Before the best entry points are gone, act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.